Barrow Hanley Mewhinney & Strauss LLC Surmodics Inc Transaction History
Barrow Hanley Mewhinney & Strauss LLC
- $29.7 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding SRDX
# of Institutions
156Shares Held
11.8MCall Options Held
219KPut Options Held
255K-
Black Rock Inc. New York, NY1.17MShares$48.7 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY887KShares$36.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA810KShares$33.7 Million0.0% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I0610KShares$25.4 Million0.69% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT536KShares$22.3 Million0.06% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $583M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...